BACKGROUND: Hypoxia-inducible factor-1 alpha (HIF-1α) P582S polymorphism has been reported to increase transactivation capacity of HIF-1α, which is prone to tumorigenesis. Several published case-control studies on the association between P582S polymorphism and cervical cancer have shown mixed results. In this study, we chose to perform a meta-analysis to assess the association. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a meta-analysis consisting of four studies with a total of 846 cases and 991 controls. All data were collected and overall comparison was performed among all subjects. Using the fixed effects model, the homozygous and the recessive models showed a significant increase in the risk of cervical cancer (the pooled OR=6.32, 95% CI=2.28-17.55, Phet=0.348; the pooled OR=5.86, 95% CI=2.13-16.11, Phet=0.394 respectively). Publication bias was not significantly indicated in this analysis. CONCLUSIONS: This meta-analysis demonstrates that HIF-1α P582S polymorphism may be associated with the risk of cervical cancer.
BACKGROUND:Hypoxia-inducible factor-1 alpha (HIF-1α) P582S polymorphism has been reported to increase transactivation capacity of HIF-1α, which is prone to tumorigenesis. Several published case-control studies on the association between P582S polymorphism and cervical cancer have shown mixed results. In this study, we chose to perform a meta-analysis to assess the association. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a meta-analysis consisting of four studies with a total of 846 cases and 991 controls. All data were collected and overall comparison was performed among all subjects. Using the fixed effects model, the homozygous and the recessive models showed a significant increase in the risk of cervical cancer (the pooled OR=6.32, 95% CI=2.28-17.55, Phet=0.348; the pooled OR=5.86, 95% CI=2.13-16.11, Phet=0.394 respectively). Publication bias was not significantly indicated in this analysis. CONCLUSIONS: This meta-analysis demonstrates that HIF-1α P582S polymorphism may be associated with the risk of cervical cancer.
Authors: P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe Journal: Nature Date: 1999-05-20 Impact factor: 49.962
Authors: R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall Journal: J Natl Cancer Inst Date: 2001-02-21 Impact factor: 13.506
Authors: Ruth Foley; Laure Marignol; Arun Z Thomas; Ivor M Cullen; Antoinette S Perry; Prerna Tewari; Anthony O'Grady; Elaine Kay; Barbara Dunne; Barbara Loftus; William R Watson; John M Fitzpatrick; Karen Woodson; Terri Lehman; Donal Hollywood; Thomas H Lynch; Mark Lawler Journal: Cancer Biol Ther Date: 2009-02-01 Impact factor: 4.742
Authors: Gabriela Antonio-Andres; Gustavo U Martinez-Ruiz; Mario Morales-Martinez; Elva Jiménez-Hernandez; Estefany Martinez-Torres; Tania V Lopez-Perez; Laura A Estrada-Abreo; Genaro Patino-Lopez; Sergio Juarez-Mendez; Víctor M Davila-Borja; Sara Huerta-Yepez Journal: Int J Mol Sci Date: 2022-02-02 Impact factor: 5.923